Xeris Biopharma Holdings Inc (NASDAQ: XERS) is 46.02% higher on its value in year-to-date trading and has touched a low of $1.73 and a high of $6.07 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The XERS stock was last observed hovering at around $5.01 in the last trading session, with the day’s loss setting it -0.06%.
Currently trading at $4.95, the stock is 11.62% and 6.29% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.01 million and changing -1.20% at the moment leaves the stock 40.95% off its SMA200. XERS registered 167.57% gain for a year compared to 6-month gain of 48.20%.
The stock witnessed a 25.32% loss in the last 1 month and extending the period to 3 months gives it a 38.66%, and is 6.68% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.78% over the week and 6.37% over the month.
Xeris Biopharma Holdings Inc (XERS) has around 394 employees, a market worth around $762.00M and $222.55M in sales. Fwd P/E is 43.19. Profit margin for the company is -20.25%. Distance from 52-week low is 186.13% and -18.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-20.91%).
The EPS is expected to grow by 79.06% this year.
Xeris Biopharma Holdings Inc (XERS) Top Institutional Holders
The shares outstanding are 156.01M, and float is at 147.66M with Short Float at 11.67%.
The top institutional shareholder in the company is BLACKROCK INC. with over 10.33 million shares valued at $23.25 million. The investor’s holdings represent 6.9649% of the XERS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 7.66 million shares valued at $17.23 million to account for 5.1615 of the shares outstanding. The other top investors are CAXTON CORP which holds 5.11 million shares representing 3.4469% and valued at over $11.51 million, while BIOIMPACT CAPITAL LLC holds 3.2563 of the shares totaling 4.83 million with a market value of $10.87 million.
Xeris Biopharma Holdings Inc (XERS) Insider Activity
#####
Xeris Biopharma Holdings Inc disclosed in a document filed with the SEC on Mar 20 ’25 that Hecht Bethsold a total of 40,000 shares of the company’s common stock. The trade occurred on Mar 20 ’25 and was made at $5.43 per share for $0.22 million. Following the transaction, the insider now directly holds 1.35 million shares of the XERS stock.
Still, SEC filings show that on Mar 20 ’25, Hecht Beth (Officer) Proposed Sale 40,000 shares at an average price of $5.14 for $0.21 million. The insider now directly holds shares of Xeris Biopharma Holdings Inc (XERS).
